NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
Last trade$0.1813
Day change-$0.0237 (-11.56%)
Day range$0.167 – $0.212
Volume595,181
Market cap$0M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for NIVF.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for NIVF.
Recent news
Company coverage with links to the original publishers.
NewGen Group Limited (Nasdaq: NIVF) announced a Big Four valuation of US$19 million for its planned UAE-based cell sorting and cytometry leasing business, building on a prior US$17.9 million IP valuation. The company appointed industry veteran Nadeem Malik as Senior Strategic Advisor to lead the UAE/GCC expansion, targeting the high-growth IVF market projected to surge from US$270 million in 2024 to US$444 million by 2030. The initiative aims to capture domestic demand and medical tourism from China and India while leveraging synergies with NewGen's Ras Al Khaimah real estate projects.
NewGenIvf Group (NASDAQ: NIVF) shares surged 67.8% in premarket trading on Wednesday following the company's announcement to repurchase all outstanding convertible notes and warrants from a significant investor. The move aims to strengthen the capital structure, eliminate potential dilution, and provide greater clarity for shareholders. The stock is trading 43.4% above its 20-day moving average with bullish technical indicators.
NewGenIvf Group acquired advanced cytometry intellectual property, receiving a valuation of $17.9 million, which boosts the company's net asset value and marks a strategic transition from traditional IVF services to a technology-driven service provider.
NewGenDigital, a subsidiary of NewGenIvf Group, has secured a strategic 110,400 sq. ft. plot in Ras Al Khaimah, UAE, and is exploring real world asset tokenization using blockchain technology, with potential sales revenue exceeding $400 million.
NewGenIVF, a fertility services provider in Asia, has terminated its proposed reverse merger transaction with European Wellness Investment Holdings Limited due to the latter's failure to deliver required financial statements by the deadline.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.